title: [Irinotecan hydrochloride for treatment of advanced breast cancers].
authors.affiliation: Second Department of Surgery, Osaka City University Medical School.
authors.forename: K
authors.initials: K
authors.lastname: Morimoto
authors.forename: M
authors.initials: M
authors.lastname: Kou
authors.forename: H
authors.initials: H
authors.lastname: Kinoshita
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000493:pharmacokinetics / Q000494:pharmacology; D001943:Breast Neoplasms / Q000188:drug therapy*; D002166:Camptothecin / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology; D017322:Clinical Trials, Phase II as Topic; D005260:Female; D006801:Humans; D000077146:Irinotecan; D059004:Topoisomerase I Inhibitors
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D059004:Topoisomerase I Inhibitors; D000077146:Irinotecan; D002166:Camptothecin